Medistim — Earnings Release 2015

Apr 24, 2015

Results for first quarter 2015 for Medistim ASA

Results for first quarter 2015 for Medistim ASA

Sales for the quarter ended at MNOK 57.9 (MNOK

48.9), an increase of 18.5 %. Operating profit

(EBIT) ended at MNOK 9.9 (MNOK 7.2), up 36.7 %.

There was a strong development in sales in the US

with an increase in sales with 50 %. Currency

neutral growth in the US was 19 %. VeriQC was

cleared for sale in China during the quarter.

Medtronic is not renewing the distribution agreement

with Medistim Norge AS.